Targeted Delivery of siRNA Therapeutics to Malignant Tumors (original) (raw)

Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

Raymond Schiffelers

Nucleic Acids Research, 2004

View PDFchevron_right

Recent Targeted of siRNA Delivery Vehicles for Cancer Therapy

Professor Dr. Loutfy H . Madkour

Biomedical Journal of Scientific & Technical Research, 2021

View PDFchevron_right

Insights on prospects of nano-siRNA based approaches in treatment of Cancer

Mr. Rajat Goyal, Kamal Dua

Frontiers in Pharmacology , 2022

View PDFchevron_right

83. Cell-Type Specific Delivery of siRNAs with Aptamer-siRNA Chimeras

Paloma Giangrande, Eli Gilboa

Molecular Therapy, 2006

View PDFchevron_right

Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment

Dima Hattab

Pharmaceutics, 2021

View PDFchevron_right

Targeted siRNA nanocarrier: a platform technology for cancer treatment

Matias Ezequiel Gutierrez Suburu

Oncogene, 2022

View PDFchevron_right

Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras

Paloma Giangrande

Nature Biotechnology, 2006

View PDFchevron_right

Efficient siRNA-peptide conjugation for specific targeted delivery into tumor cells

Isabelle Brun Heath

Chemical communications (Cambridge, England), 2017

View PDFchevron_right

siRNA Delivery Technology for Cancer Therapy: Promise and Challenges

Fateme Karimi

ACTA MEDICA IRANICA, 2019

View PDFchevron_right

Cell-specific siRNA delivery by peptides and antibodies

Tarek Fahmy

Methods in enzymology

View PDFchevron_right

siRNA-based Nanoparticles for Cancer Therapy: Hurdles and Hopes

Professor moffatt

View PDFchevron_right

Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?

Caitriona O'Driscoll

Biotechnology Advances, 2011

View PDFchevron_right

Tumor-targeted Delivery of siRNA by Self-assembled Nanoparticles

sds li

Molecular Therapy, 2008

View PDFchevron_right

Toward a siRNA-containing nanoparticle targeted to breast cancer cells and the tumor microenvironment

Sérgio Simões

International Journal of Pharmaceutics, 2012

View PDFchevron_right

Materializing the Potential of Small Interfering RNA via a Tumor-Targeting Nanodelivery System

Guillermo Palchik

Cancer research, 2007

View PDFchevron_right

Towards a siRNA-containing nanoparticle targeted to breast cancer cells and the tumor microenvironment

Sérgio Simões

International journal of pharmaceutics, 2012

View PDFchevron_right

Current Scene and Prospective Potentials of siRNA in Cancer Therapy

RAKESH K TEKADE

View PDFchevron_right

Identification and Characterization of Receptor-Specific Peptides for siRNA Delivery

Sabine Hauert

ACS nano, 2012

View PDFchevron_right

Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of Cancer

Dilson Silva

Pharmaceutics

View PDFchevron_right

Efficient and targeted delivery of siRNA in vivo

Min Shim

FEBS Journal, 2010

View PDFchevron_right

Delivery of gene targeting siRNAs to breast cancer cells using a multifunctional peptide complex that promotes both targeted delivery and endosomal release

Andy Pang

PLOS ONE

View PDFchevron_right

Targeted siRNA Delivery and mRNA Knockdown Mediated by Bispecific Digoxigenin-binding Antibodies

Ulrich Brinkmann

Molecular Therapy — Nucleic Acids, 2012

View PDFchevron_right

Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells

Corinna Palanca-wessels

Oncotarget, 2016

View PDFchevron_right

Targeted Delivery of siRNA

Raymond Schiffelers

Journal of Biomedicine and Biotechnology, 2006

View PDFchevron_right

EpCAM-targeted delivery of nanocomplexed siRNA to tumor cells with designed ankyrin repeat proteins

Andreas Plückthun

View PDFchevron_right

Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid

Kuniaki Nagayama

Biomaterials, 2011

View PDFchevron_right

siRNA Delivery Strategies: A Comprehensive Review of Recent Developments

sushil kashaw

Nanomaterials (Basel, Switzerland), 2017

View PDFchevron_right

Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells

Lisa Agnello

Pharmaceutics

View PDFchevron_right

siRNA nanoparticles: the future of RNAi therapeutics for oncology?

James Mixson

Nanomedicine, 2014

View PDFchevron_right

Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo

Jimmy Bell

Journal of Controlled Release, 2011

View PDFchevron_right

Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy

Neelam Balekar

Drug Delivery and Translational Research, 2017

View PDFchevron_right

RNAi Therapeutics: Current Status of Nanoncologic siRNA Delivery Systems

Murugan Ramalingam

Journal of Bionanoscience, 2011

View PDFchevron_right

Advances in systemic siRNA delivery

Archibald Mixson

Drugs of the Future, 2009

View PDFchevron_right

Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers

luiza I hernandez

Nucleic Acids Research, 2012

View PDFchevron_right